Helmerich & Payne
HPAbove valueHeld by 3 superinvestors.
SEC 10-K · fundamentals
Business quality
as of 2025-09-30Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.
- Revenue growth
- +34.0%
- Net margin
- -4.4%
- ROE
- -5.8%
- FCF margin
- 3.2%
Valuation · value band
Above fair value
$21 value estimate
Helmerich & Payne (HP): A conservative earnings-power estimate, $21 / sh; today’s price sits above it (price $44 as of 2026-08-20).
Zero-growth downside $21
Price as of 2026-08-20 · yahoo.
Method & numbers
A conservative intrinsic-value band (zero-growth floor to growth-capped DCF) plus a tangible asset floor — not investment advice, not a buy/sell signal, and not a price target.
· Greenwald zero-growth $20.64 · zero-growth base $20.64 · reproduction $20.64
Moat Below asset base.
Graham earnings-power value (normalized NOPAT)$2.82 – $7.12 / sh
Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.
Years: TTM 2026-06-30, 2024, 2023, 2022, 2021
v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 62% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back).
Buffett owner-earnings value
Normalized owner earnings are non-positive over the years shown; earnings power cannot be capitalized.
Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 9–11% rate band (read as a cost-of-equity proxy). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).
Years: TTM 2026-06-30, 2024, 2023, 2022, 2021
v1 simplifications: Net income is below its multi-year average (cyclical/declining): normalized owner earnings anchored to the latest year — no peak-earnings capitalization (audit #2). Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). Maintenance-capex methods diverge by 62% (> 50%); estimate is degraded. One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the 9–11% band as a cost-of-equity proxy; no leverage premium applied. Net debt or owner earnings is unavailable, so no adjustment is made.
Reproduction value = tangible net assets $2.06B = $20.64 / sh. Tangible net assets = shareholders' equity − goodwill − intangibles, ÷ diluted shares (no R&D history to capitalize).
Moat reading: Franchise test compares earnings power (EPV) against reproduction value on both AV_conservative (tangible + capitalized R&D) and AV_reproduction (conservative + acquired-reset proxy). Both must clear the franchise multiple for a moat signal; near it, a commodity; below it, value destruction. A directional reading, not a verdict.
Growth value gated to zero — no moat or ROIIC ≤ WACC, so no growth value is credited.
Window TTM 2026-06-30, FY 2024, 2023, 2022, 2021 · discount band 9%–11% · normalized tax 0% (Average effective tax rate over 5 year(s), capped at the statutory 21%.) · diluted shares.
Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.
How to read intrinsic valueSEC 13F · holders
Superinvestors Holding This Security
3 holders · $55.6M combined · this quarter +0 opened / -0 exited
- Value$38.5MWeight (prev→now)2.2% → 1.5% ▼
- Value$15.5MWeight (prev→now)0.0% → 0.1% ▲
- Value$1.7MWeight (prev→now)0.1% → 0.1% ▼
SEC 13F · notes
Written summary
Written summary
Helmerich & Payne (HP) is held by 3 of the superinvestors tracked on Compounder, with a combined $55.6M in reported 13F value. The largest position belongs to Prem Watsa, where it makes up 1.5% of the portfolio.
Other notable holders by value include Ray Dalio (0.1% of its book) and Tweedy, Browne (0.1% of its book).
Over the latest quarter, 0 of the tracked filers opened a new position in HP, 2 added to existing ones, 0 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
SEC 13F · co-ownership
Also held by these investors
Investors holding Helmerich & Payne (HP) also commonly hold →
- Johnson & JohnsonJNJ3 holders
- Molson Coors Beverage Co - BTAP3 holders
- Lululemon Athletica IncLULU3 holders
- Alphabet Inc-Cl AGOOGL2 holders
- Kraft Heinz Co/TheKHC2 holders
- Cvs Health CorpCVS2 holders
HP's price is not below its conservative value band. See current strike-zone stocks
Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Stay Updated
New-quarter 13F moves and valuation updates, to your inbox.